| Dr Carolina Tanzer, DO | |
|
230 E Ridgewood Ave, Paramus, NJ 07652-4142 | |
| (201) 967-4132 | |
| Not Available |
| Full Name | Dr Carolina Tanzer |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Geriatric Psychiatry |
| Location | 230 E Ridgewood Ave, Paramus, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225266695 | NPI | - | NPPES |
| 03973342 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0805X | Psychiatry & Neurology - Geriatric Psychiatry | 271691 (New York) | Primary |
| Entity Name | Maimonides Department Of Psychiatry Fpp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376656710 PECOS PAC ID: 0042115487 Enrollment ID: O20031129000000 |
News Archive
Webmedx, the fourth largest medical transcription service provider in the U.S. and a premier supplier of clinical documentation technology, today announced that Methodist Health System of Dallas (Methodist) has signed an agreement to implement Webmedx's Transcription Outsourcing Service and Enterprise(TM) software solution. A web-native system for transcription and content management, the platform will support Methodist's transcription needs and interface with the organization's electronic health record (EHR).
Game theory can be utilized to identify potential flaws in current cancer treatment approaches and suggest new strategies to improve outcomes in patients with metastatic cancer, according to a new article published online today by JAMA Oncology.
AstraZeneca and Rigel Pharmaceuticals today announced an exclusive worldwide license agreement for the global development and commercialization of fostamatinib disodium (R788), Rigel's late-stage investigational product for rheumatoid arthritis (RA) and additional indications.
More than half of older adults with clinical depression don't get better when treated with an antidepressant. But results from a multicenter clinical trial that included Washington University School of Medicine in St. Louis indicates that adding a second drug — an antipsychotic medication — to the treatment regimen helps many of those patients.
Ironwood Pharmaceuticals, Inc. today announced that its European partner Almirall, S.A. submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for linaclotide, a guanylate cyclase type-C (GC-C) agonist, for the treatment of irritable bowel syndrome with constipation.
› Verified 4 days ago
| Entity Name | Maimonides Faculty Practice Plan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053344846 PECOS PAC ID: 7012808348 Enrollment ID: O20040324000597 |
News Archive
Webmedx, the fourth largest medical transcription service provider in the U.S. and a premier supplier of clinical documentation technology, today announced that Methodist Health System of Dallas (Methodist) has signed an agreement to implement Webmedx's Transcription Outsourcing Service and Enterprise(TM) software solution. A web-native system for transcription and content management, the platform will support Methodist's transcription needs and interface with the organization's electronic health record (EHR).
Game theory can be utilized to identify potential flaws in current cancer treatment approaches and suggest new strategies to improve outcomes in patients with metastatic cancer, according to a new article published online today by JAMA Oncology.
AstraZeneca and Rigel Pharmaceuticals today announced an exclusive worldwide license agreement for the global development and commercialization of fostamatinib disodium (R788), Rigel's late-stage investigational product for rheumatoid arthritis (RA) and additional indications.
More than half of older adults with clinical depression don't get better when treated with an antidepressant. But results from a multicenter clinical trial that included Washington University School of Medicine in St. Louis indicates that adding a second drug — an antipsychotic medication — to the treatment regimen helps many of those patients.
Ironwood Pharmaceuticals, Inc. today announced that its European partner Almirall, S.A. submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for linaclotide, a guanylate cyclase type-C (GC-C) agonist, for the treatment of irritable bowel syndrome with constipation.
› Verified 4 days ago
| Entity Name | North Shore - Lij Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
Webmedx, the fourth largest medical transcription service provider in the U.S. and a premier supplier of clinical documentation technology, today announced that Methodist Health System of Dallas (Methodist) has signed an agreement to implement Webmedx's Transcription Outsourcing Service and Enterprise(TM) software solution. A web-native system for transcription and content management, the platform will support Methodist's transcription needs and interface with the organization's electronic health record (EHR).
Game theory can be utilized to identify potential flaws in current cancer treatment approaches and suggest new strategies to improve outcomes in patients with metastatic cancer, according to a new article published online today by JAMA Oncology.
AstraZeneca and Rigel Pharmaceuticals today announced an exclusive worldwide license agreement for the global development and commercialization of fostamatinib disodium (R788), Rigel's late-stage investigational product for rheumatoid arthritis (RA) and additional indications.
More than half of older adults with clinical depression don't get better when treated with an antidepressant. But results from a multicenter clinical trial that included Washington University School of Medicine in St. Louis indicates that adding a second drug — an antipsychotic medication — to the treatment regimen helps many of those patients.
Ironwood Pharmaceuticals, Inc. today announced that its European partner Almirall, S.A. submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for linaclotide, a guanylate cyclase type-C (GC-C) agonist, for the treatment of irritable bowel syndrome with constipation.
› Verified 4 days ago
| Entity Name | Hospitalist Healthcare Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275962011 PECOS PAC ID: 1557599313 Enrollment ID: O20140124001195 |
News Archive
Webmedx, the fourth largest medical transcription service provider in the U.S. and a premier supplier of clinical documentation technology, today announced that Methodist Health System of Dallas (Methodist) has signed an agreement to implement Webmedx's Transcription Outsourcing Service and Enterprise(TM) software solution. A web-native system for transcription and content management, the platform will support Methodist's transcription needs and interface with the organization's electronic health record (EHR).
Game theory can be utilized to identify potential flaws in current cancer treatment approaches and suggest new strategies to improve outcomes in patients with metastatic cancer, according to a new article published online today by JAMA Oncology.
AstraZeneca and Rigel Pharmaceuticals today announced an exclusive worldwide license agreement for the global development and commercialization of fostamatinib disodium (R788), Rigel's late-stage investigational product for rheumatoid arthritis (RA) and additional indications.
More than half of older adults with clinical depression don't get better when treated with an antidepressant. But results from a multicenter clinical trial that included Washington University School of Medicine in St. Louis indicates that adding a second drug — an antipsychotic medication — to the treatment regimen helps many of those patients.
Ironwood Pharmaceuticals, Inc. today announced that its European partner Almirall, S.A. submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for linaclotide, a guanylate cyclase type-C (GC-C) agonist, for the treatment of irritable bowel syndrome with constipation.
› Verified 4 days ago
| Entity Name | New York General Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700315538 PECOS PAC ID: 7810255494 Enrollment ID: O20180103003151 |
News Archive
Webmedx, the fourth largest medical transcription service provider in the U.S. and a premier supplier of clinical documentation technology, today announced that Methodist Health System of Dallas (Methodist) has signed an agreement to implement Webmedx's Transcription Outsourcing Service and Enterprise(TM) software solution. A web-native system for transcription and content management, the platform will support Methodist's transcription needs and interface with the organization's electronic health record (EHR).
Game theory can be utilized to identify potential flaws in current cancer treatment approaches and suggest new strategies to improve outcomes in patients with metastatic cancer, according to a new article published online today by JAMA Oncology.
AstraZeneca and Rigel Pharmaceuticals today announced an exclusive worldwide license agreement for the global development and commercialization of fostamatinib disodium (R788), Rigel's late-stage investigational product for rheumatoid arthritis (RA) and additional indications.
More than half of older adults with clinical depression don't get better when treated with an antidepressant. But results from a multicenter clinical trial that included Washington University School of Medicine in St. Louis indicates that adding a second drug — an antipsychotic medication — to the treatment regimen helps many of those patients.
Ironwood Pharmaceuticals, Inc. today announced that its European partner Almirall, S.A. submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for linaclotide, a guanylate cyclase type-C (GC-C) agonist, for the treatment of irritable bowel syndrome with constipation.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carolina Tanzer, DO 230 E Ridgewood Ave, Paramus, NJ 07652-4142 Ph: () - | Dr Carolina Tanzer, DO 230 E Ridgewood Ave, Paramus, NJ 07652-4142 Ph: (201) 967-4132 |
News Archive
Webmedx, the fourth largest medical transcription service provider in the U.S. and a premier supplier of clinical documentation technology, today announced that Methodist Health System of Dallas (Methodist) has signed an agreement to implement Webmedx's Transcription Outsourcing Service and Enterprise(TM) software solution. A web-native system for transcription and content management, the platform will support Methodist's transcription needs and interface with the organization's electronic health record (EHR).
Game theory can be utilized to identify potential flaws in current cancer treatment approaches and suggest new strategies to improve outcomes in patients with metastatic cancer, according to a new article published online today by JAMA Oncology.
AstraZeneca and Rigel Pharmaceuticals today announced an exclusive worldwide license agreement for the global development and commercialization of fostamatinib disodium (R788), Rigel's late-stage investigational product for rheumatoid arthritis (RA) and additional indications.
More than half of older adults with clinical depression don't get better when treated with an antidepressant. But results from a multicenter clinical trial that included Washington University School of Medicine in St. Louis indicates that adding a second drug — an antipsychotic medication — to the treatment regimen helps many of those patients.
Ironwood Pharmaceuticals, Inc. today announced that its European partner Almirall, S.A. submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for linaclotide, a guanylate cyclase type-C (GC-C) agonist, for the treatment of irritable bowel syndrome with constipation.
› Verified 4 days ago
Dr. Erica Rae Schiffman, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 230 E Ridgewood Ave, Paramus, NJ 07652 Phone: 201-967-4229 Fax: 201-967-4413 | |
Theodore Joseph Conte, MD, Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 22 Madison Ave Ste 206, Paramus, NJ 07652 Phone: 201-291-8489 Fax: 201-291-8487 | |
Dr. Natasha Grace Baron, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 230 E Ridgewood Ave, Paramus, NJ 07652 Phone: 201-967-4000 | |
Dr. Michael Richard Harrigan, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 230 E Ridgewood Ave, Dept Of Psychiatry, Paramus, NJ 07652 Phone: 201-967-4132 | |
Richard A Winters, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 29 North Farview Avenue, Paramus, NJ 07652 Phone: 201-843-4944 Fax: 201-265-7647 | |
Dr. Sara M Calvert, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 6 Forest Ave, Paramus, NJ 07652 Phone: 201-587-7850 Fax: 201-587-0707 | |
Alessandra Grazia Santamaria, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 230 E Ridgewood Ave, Paramus, NJ 07652 Phone: 201-967-4000 |